Introduction. Objectives
|
|
- Godwin Knight
- 5 years ago
- Views:
Transcription
1 A Research Personnel Model to Maximize Compliance Carol Fedor, RN, ND, CCRC Director, Human Research Protection Program Center for Clinical Research and Technology University Hospitals Case Medical Center HCCA Research Compliance Annual Conference Austin, Texas June 1, 2013 Introduction Challenges that impact Research Sites: Regulatory burden on investigators Protected time for investigators to conduct research Recruitment and retention of research participants Retention of qualified clinical research personnel Economic pressures AMCs less likely able to support funding gaps between contracts/grants Inadequate clinical research personnel allocation in budget Overall inadequate budget 2 Objectives 1. Identify alternative model for effectively managing clinical research personnel. 2. Analyze benefits of a centralized clinical research personnel pool to the overall operations and management of research personnel in an academic medical center (AMC). 3 1
2 Background Clinical research coordinators (CRC) function in many roles and emerge as the key figure in the clinical research process. Recruitment/enrollment Regulatory documentation Data management Study visit assessments Informed consent Adverse event management Managing the Investigators 4 Background Often, CRCs are hired by a principal investigator under the auspices of an institution based on the availability of grant funding. Research personnel are typically based within the department (decentralized) and report to the PI and/or Administrator. 5 Proposition Centralized oversight and support of research personnel has operational advantages Efficiency Cost savings Continuity of funding Availability of backup personnel Uniform performance of personnel Improve collaborative research environment Uniform operating procedures and training that improve compliance Uniform standards for the qualifications and experience of support personnel 6 2
3 Case Study University Hospitals Case Medical Center (UHCMC) in Cleveland, Ohio established a research support core program to build a clinical research infrastructure within the Center for Clinical Research and Technology (CCRT) to support the research community with qualified Clinical Research Specialists on an as needed fee-for-service basis. 7 Model Centralized across 21 academic and clinical departments in the AMC. Standardized competencies of positions and job descriptions of all clinical research personnel. Established governance by central research administration. 8 Model (continued) A centralized framework providing uniform oversight and ensuring efficiency and cost distribution. Consistent approach to study management. Professionalizes clinical research support personnel. Flexibility and coverage increased. 9 3
4 Institutional Collaboration: Research and Human Resources CRC job descriptions were developed into task specific positions based on the level of responsibilities with Department of Human Resources and representatives from the clinical and academic departments. Goal to streamline job titles and descriptions to promote career development and increase retention. Positions were developed based on a grid matrix: years of clinical research experience, education, research certifications and responsibilities associated with the role. 10 Center for Clinical Research: Support Services TYPE OF ROLE OR POSITION Clinical Research Nurse Specialists Clinical Research Specialists Clinical Research Regulatory Specialists Research Finance Specialists Grant Support Specialists Clinical Research Data Specialists LEVELS/JOB DESCRIPTIONS (Levels I to IV) (Levels I to III) (Levels I to III) (Levels I to III) (Levels I and II) (Levels I to III) 11 Research Regulatory Specialist Career Pathway Matrix Job Level Experience Education Responsibilities Research Regulatory Specialist I Research Regulatory Specialist II Research Regulatory Specialist III 2 years in a health-related or research field Associate s degree preferred; degree can substitute for years experience 3 years of clinical research Bachelor s degree required; years of experience and research certification (i.e., SoCRA or ACRP) can offset degree requirement 3 years of clinical research regulatory OR 5 years of clinical research Required bachelor s degree AND advanced degree or research Certification (SoCRA or ACRP) See General Job Description Includes responsibilities of the RRS-I job description and coordinates multiple or complex studies or/and investigator initiated IND-IDE held studies with minimal supervision. Prepares FDA submissions for IND or IDE held Investigator Initiated Trials. Assists Principal Investigators with protocol and consent writing. Provides mentorship on the clinical trial and regulatory process to less experienced staff members. Includes responsibilities of the RRS- II and assists with workload review of team and provide guidance on task prioritization. Mentors new hires in training on departmental processes and policies. Assists in SOP development. Oversees and implements department wide projects. Projects require research, organization, 12 4
5 Personnel Requirements The Clinical Research Specialists (CRS) have extensive experience in the coordination and management of a clinical trial. Individuals are credentialed in their specialized area of research conduct or administration. CRS receive training (CCRT) to be experts in regulatory requirements and comply with institutional policies. 13 Process: Request for Research Support Investigator meeting to identify protocol specific support Complete Research Specialist Request Form (requires grant account number) Identify Research Specialist level/personnel who best fits the project Request Form reviewed by Director, Human Research Protection Program and Vice President for Research Develop orientation for CRS to department and assignment 14 Research Administration Operations Research Request Form Time Tracking Defining Activities Cross-charging (post award grant accountants) 15 5
6 CRS Request Form SECTION 1 Instructions: Please complete the following form and to carol.fedor@uhhospitals.org Principal Investigator (PI) Date of request (MM/DD/YY) Title/Position Department Division Phone Number/Pager Project Short Title: IRB #: Approval date: Funding Source Federal Funded Industry-sponsored Foundation Department Investigator Initiated Projected start date (MM/DD/YY): Projected end date (MM/DD/YY): % FTE Estimate: Financial contact Account number (PTAEO) Drug Study? Device Study? No Yes No Yes Will the W.T. Dahms Clinical Research Unit (DCRU) be used? No Yes Department Review Completed? Yes No If the DCRU will not be used, please list the location(s) for the study visits: SECTION 2 Brief Study description (Provide Copy of Protocol & Consent Form): Categories of Research Support Site qualification Site Initiation Case Report Form development Regulatory Binder Investigator/team training Coverage analysis Protocol development IND/IDE Applications to FDA Study visit conduct Data collection Informed Consent IRB documentation Adverse event reporting Drug/device accountability FDA/Sponsor audit prep Monitoring 17 10/1/ University Hospitals Case Medical Center Time Tracking Hours Study Start-Up 0.00 ClinicalTrials.gov Registration 0.00 Coverage Analysis and Pre-Qualification Forms Assistance 1.00 Contract/Agreement/financial/coordination setup support IRB New Study Application 5.00 Protocol Development 0.00 Regulatory Binder Creation/Set-Up 2.00 Required Training 5.00 Site Initiation/Protocol Implementation 1.00 Sponsor Correspondence 0.00 Study Document Creation 0.00 Study PI/Sponsor Educational Training 6
7 Time Tracking Hours: Study Maintenance 0 Adverse Event Reporting 0 Case Report Forms Edits/Change 3 Data Management 0 Data Safety Monitoring Report Assistance 0 Investigator/Team Meeting 0 iris Protocol Registration 0 Meeting Minute Documentation 7 Protocol Amendment 18 Protocol Continuing Review 0 Protocol Deviation Report 1 Regulatory Binder Organizational Assistance 1 Required Training 0 Study PI/Sponsor Educational Training 0 Subject Recruitment Strategies Time Tracking Hours IND/IDE Assistance 0 Annual Report Assistance 0 FDA Protocol Amendment Submission 0 Final Report Assistance 0 IDE Application Assistance 0 IND Application Assistance 0 Med Watch Report Submission 0 Monitoring Plan Evaluation 0 Pre-IND Application 0 Pre-IDE Application 0 Protocol Analysis for IND/IDE Determination 0 Study PI/Sponsor Educational Training Institutional Research Support Core Development First Research Specialist hired Hired second Regulatory Specialist Hired 2 additional Regulatory Specialists and 1 Regulatory Nurse Specialist Hired 1 Regulatory Specialist and 1 Research Nurse Specialist Department 11 Protocols Total 3 Departments 20 Protocols Total 6 Departments 46 Protocols Total 9 Departments 111 Protocols Total 14 Departments 208 Protocols 21 7
8 Results To date these five positions included in this pilot have participated in the management or conduct of 203 clinical protocols based across 14 clinical departments and provide support to more than 90 investigators. 22 Research Support Core Growth Total Projects by Department University Hospitals Total Projects 213 Total Projects 18 Departments
9 Advantages of Model Research Specialists are hired, trained and supervised by the central research office and have access to entire research administration office. IRB administration, pre-award, post-award, research billing, research compliance and education Specialists have extensive experience (4 10 years), certified clinical research professionals, advanced degrees (Master s) and are required to complete the Clinical Research Orientation program. Emphasis on education to advance role FDA and the Office of Human Research Protections (OHRP) conferences Individualized training in IRB submission processes 25 Business Model: Growth and Quality of Site Performance Increased regulatory compliance with ability to effectively submit documents efficiently to the IRB and to the FDA when required. Increased implementation of complex investigator initiated protocols at UHCMC that met enrollment quotas efficiently; without the expertise of the research support core, these types of protocols can be high risk to the institution. Increased research funding due to increased start-up potential of studies in the institution and increased enrollment due to qualified personnel available within the support core. Engage new PIs without resources. 26 Lessons Learned Transitioning existing support personnel under central research administration. Improves job security Reinforces clinical research career paths. Expands training and educational knowledge base (e.g. IND\IDE regulatory filings, research billing related topics, GCP) Increased human subject protections for higher risk protocols. 27 9
10 Conclusions (continued) Impact on industry funded-clinical trial budgets while producing real time results. Institutions often offset the costs of conducting clinical trials because investigators may underestimate the percent effort required by study personnel to complete all required aspects of a trial; research support core model realistically captures the actual cost of those functions. Industry will likely support these actual costs if in return protocols are conducted with increased efficiency, improved human subject protections and with increased data integrity. 28 Future State Grow to meet demands Collaborate in assessing study feasibility Transition existing positions under the central administration hierarchy. Expands educational support available based on knowledge of Specialists Build institutional reputation and minimize non-compliance. 29 References Cola, P., Mihalus, S., and Fedor, C. Prioritizing Clinical Research Resources: Development of a Centralized Research Support Core, Monitor, Lloyd-Damnjanovic, A. & Rome, H. (2011). Research in jeopardy: scientists fear funding loss. The Daily Princetonian. Published: Wednesday, April 6 th, Bloom, F. E. (2003). Science as a way of life: Perplexities of a physician-scientist. Science, 300(5626), Dickler, H.B., Korn, D., & Gabbe, S. G. (2006). Promoting translational and clinical science: The critical role of medical schools and teaching hospitals. PloS Medicine, 3(9), Sung, N. S., Crowley, W. F.,Jr, Genel, M., Salber, P., Sandy, L., Sherwood, L. M., et al. (2003). Central challenges facing the national clinical research enterprise. JAMA : The Journal of the American Medical Association, 289(10), Huang, A. J. (1999). Reinventing the physician-scientist in the new era of health care. JAMA : The Journal of the American Medical Association, 281(1), 94. Kim, S, Ubel, P, De Vries, R. Pruning the regulatory tree. Nature. 2009; 457:
11 References (Continued) Sugarman, J. (2000). The role of institutional support in protecting human research subjects. Academic Medicine, Vol. 75 (7), Fedor, C. & Cola, P.A. (2003). The Coordinators Forum: Preliminary results of the Clinical Researcher Coordinators Survey. Clinical Researcher, 3 (4), Fedor, C.A. (2006). Chapter 1: The evolving role of the clinical research coordinator. Responsible Research: A Guide for Coordinators. Edited by Carol A. Fedor, Philip A. Cola & Christine Pierre. Remedica Publishing, London, UK. Pages Fedor, C.A. & Gabriele, E.F. (2006). Chapter 13: Future trends: the professionalization of the CRC. Responsible Research: A Guide for Coordinators. Edited by Carol A. Fedor, Philip A. Cola & Christine Pierre. Remedica Publishing, London, UK. Pages Acknowledgement and Thank You The presenters wish to acknowledge the support of the other members of the Research Support Core who contributed data: Lisa Archer Jill Bradisse, MA, CCRP Carmen Czich, RN, CCRP Kirk Krogstad Sonya Mihalus, RN, CCRC Jenna Stump, MS, CCRP 32 11
SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY TITLE: Satellite Site Management Plan Job Title of Reviewer: POLICY #: EFFECTIVE DATE: REVISED DATE: POLICY TYPE: Elizabeth Carr, R.N.,
More informationAugust 3, 2017 Clinical Trials at UNC. UNC Symposium for Research Administrators
August 3, 2017 Clinical Trials at UNC UNC Symposium for Research Administrators UNC Symposium for Research Administrators Presenter Christine Nelson, RN, BSN, MBA, CCRC Director, Office of Clinical Trials
More informationWIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)
WIRBinar How to Survive an FDA Inspection 10-26-2011 Brought to you by WIRB Education and Consulting Services. Improve your ability to maintain compliance and protect human subjects with guidance from
More informationClinicalTrials.gov workshop
ClinicalTrials.gov workshop Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationVCU Clinical Research Quality Assurance Assessment
VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment
More informationEssential Documents It s Not Just a Binder!
Essential Documents It s Not Just a Binder! Kelly Unsworth, MS, CCRC, CIP Director of Research Education & Training Office for Human Subject Protection SCORE June 5, 2014 But What percentage of 2014 (to
More informationClinical Research Professionals
Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2016 In-Person and Web-Based Training Courses, Customized Training, elearning and Publications for Clinical
More informationAN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES
1 AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES Key Clinical Study Tasks and Activities 2 Discussion of Key Tasks and Activities 3 Development of the Clinical Protocol and Study Materials 3 Qualification
More informationRegulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies
Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies DIRECTIONS: 1. The purpose of a regulatory binder is to assure that all essential elements are maintained in an organized
More informationThe GCP Perspective on Study Monitoring
The GCP Perspective on Study Monitoring Heidi Judge, CCRP Sr. Clinical Trials Project Manager Clinical Trials Network and Institute Massachusetts General Hospital 1 Overview Monitoring Basics Who, What,
More informationDr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015
18 August 2015 Role & Responsibilities of Principal Dr. R. Sathianathan Professor of Psychiatry, SRMC, Porur & Former Director, Institute of Mental Health, Chennai Principal Investigators & GOOD CLINICAL
More informationIRB Survival Guide! Getting Approved
IRB Survival Guide! Getting Approved Developed by Lydia Furman, MD Chairperson Department of Pediatrics Clinical Research Review Committee Vice-Chairperson Institutional Review Board, University Hospitals
More informationTITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18
SOP #: RCO-204 Page: 1 of 5 1. POLICY STATEMENT: The research team is responsible for recognizing changes in subject health that may qualify as adverse events, classifying those results as defined in the
More informationTraining & Resources for Clinical Research Professionals
a division of Cambridge Healthtech Institute Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2013 In-Person and Web-Based Training Courses, Customized
More informationMastering Clinical Research April 19, :30 am
Mastering Clinical Research April 19, 2017 7:30 am New Question and Answer Response System Log In Directions Use the following link to access pre and post test questions: http://www.socrative.com/ Click
More informationSUCCESS FEE FOR SERVICE PROGRAMS
SUCCESS GCRC Research CENTER Environment SUCCESS FEE FOR SERVICE PROGRAMS Clare Tyson, MA, CCRA Leila Forney, BSN, RN, CCRP Brigette White MA, CCRP Stephen Skelton, MA SUCCESS CENTER FEE FOR SERIVCE PROGRAMS
More informationHIC Standard Operating Procedure. For-Cause Audits of Human Research Studies
HIC Standard Operating Procedure For-Cause Audits of Human Research Studies Background As part of the Wayne State University (WSU) Human Investigation Committee s (HIC) Human Research Protection Program,
More informationIntroduction To Medpace & Clinical Research Overview
Introduction To Medpace & Clinical Research Overview Medpace Overview o o o o o We are a Contract Research Organization (CRO) Work closely with biotech, pharma, and device companies Full Service Model
More informationSTUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)
POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) Purpose: Investigators who initiate and submit an IDE application to the FDA assume the responsibilities of both
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationThe 2 nd Annual Quality in Clinical Research Conference wp.vcu.edu/qualitycr. April 28, 2017
The 2 nd Annual Quality in Clinical Research Conference wp.vcu.edu/qualitycr April 28, 2017 The Jonah L. Larrick Center Virginia Commonwealth University MCV Campus 900 Turpin Street, Richmond, Virginia
More informationPreparing for a Streamlined Ethics Review System. Janet Manzo, OCREB & CTO February 27, 2014
Preparing for a Streamlined Ethics Review System Janet Manzo, OCREB & CTO February 27, 2014 Outline Lessons -UK, US, Ontario The Road Ahead Challenges & Opportunities UK National Research Ethics Service
More informationIU ClinicalTrials.gov: Compliance Program Plan
Table of Contents Introduction 3 Section I Requirements and Recommendations A. FDAAA 801 Requirements 3 B. ICMJE Publication Requirements 4 C. CMS Billing Requirements 4 D. NIH Recommendations 4 E. IU
More informationInvestigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser
Investigator-Initiated Studies: When you re the Sponsor Cheri Robert & Tammy Mah-Fraser ACRC Clinical Research Conference Edmonton, AB October 15, 2014 Session Objectives Define roles of the investigator,
More informationEffective Date: April 2014 Revision: September 29, Executive Chair, Co-Chairs, NSHA REB Members, REB Office Personnel, Researchers.
TITLE: Standard Operating Procedure (SOP) External Inspections or Audits NUMBER: NSHA REB-SOP-9-002 Effective Date: April 2014 Revision: September 29, 2017 Applies To: Executive Chair, Co-Chairs, NSHA
More informationSelf-Monitoring Tool
This form is designed for research personnel to use to assess their compliance with TTUHSC El Paso IRB policies and procedures, and federal regulations and guidance governing research with human subjects,
More informationThe NCI Central IRB Initiative. Third Annual Medical Research Summit Washington, D.C. March 2003
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003 The NCI CIRB Initiative Began August 1999 in consultation with OHRP (OPRR) To establish a Central IRB for
More informationPresented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals
ORIENTATION FOR NEW CLINICAL RESEARCH COORDINATORS Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals Overall Agenda for Orientation Module 1: Introduction
More informationPresented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals
ORIENTATION FOR NEW CLINICAL RESEARCH COORDINATORS Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals Overall Agenda for Orientation Module 1:
More informationPublic Input for Changes to Reportable Events Policy
Public Input for Changes to Reportable Events Policy May 23, 2017 Richard Guido, MD, IRB Chair Jamie Zelazny, PhD, RN, Regulatory Affairs Specialist Outline Regulatory basis for reporting policies Importance
More informationConducting Monitoring Visits for Investigator-Initiated Trials (IITs)
Conducting Monitoring Visits for Investigator-Initiated Trials (IITs) Clinical Research Coordinator Society (CRCS) Forum 25 July 2014 Xia Yu Clinical Research Associate Singapore Clinical Research Institute
More informationSAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board
SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California STANDARD OPERATING PROCEDURES Institutional Review Board Date Effective: April 26, 2001 Index No. R 1217 Date Last Revised: 0 Date
More information11/18/2016. UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities SESSION 4
UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities BEVERLY ALGER, CCRP, CHRC Research Compliance Officer Office of Research Compliance November 2016
More informationOverview ICH GCP E6(R2) Integrated Addendum
2017 Biomedical Research Alliance of New York LLC CITI Program is a division of BRANY Overview ICH GCP E6(R2) Integrated Addendum Introduction On 15 December 2016, the International Council for Harmonistion
More informationI. Scope This policy defines unanticipated problems and adverse events and establishes the reporting process and timeline.
Human Research Protection Program Policies & Procedures Unanticipated Problems and Adverse Events Version 3.0 Date Effective: 11.9.2012 Research Integrity Office Mail code L106-RI Portland, Oregon 97239-3098
More informationStudy Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting
Study Management SM 306.00 STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick M. Schnell, MD,
More informationClinical Trial Quality Assurance Common Findings
Clinical Trial Quality Assurance Common Findings Objectives Identify common findings found in research study reviews conducted by the CTQA Program Understand what findings require an action plan vs. a
More informationGood Documentation Practices. Human Subject Research. for
Good Documentation Practices for Human Subject Research Bridget M. Psicihulis, RHIA, CCRC Quality Improvement Unit Coordinator Human Research Protection Program Wheaton Franciscan Healthcare (last updated
More informationPreparing for Audits and Post Approval Monitoring April 29, 2015
Preparing for Audits and Post Approval Monitoring April 29, 2015 Presented By: Piper Hawkins Green, CIP Olga Jonas, CIP IRB Compliance Analyst IRB Compliance Analyst Presentation Agenda Regulatory background
More informationAcademic Clinical Practice Work Group Strategic Plan DRAFT June 3, 2014
Academic Clinical Practice Work Group Strategic Plan DRAFT June 3, 2014 The Academic Clinical Practice work group conducted a SWOT exercise and considered the following questions in its deliberations on
More information4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.
SOP #: MON-101 Page: 1 of 6 1. POLICY STATEMENT: The DF/HCC understands that external sponsors are required to monitor the progress of clinical investigations and ensure appropriate research data collection
More informationOffice of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators
Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Patricia Fischer, RN, CCRP Investigator Responsibilities FDA Draft Guidance May 2007 Clarifies FDA s expectations,
More informationVascular Surgery Academic Coordinating Center (VSACC) & Peripheral Vascular Core Lab (PVCL)
Vascular Surgery Academic Coordinating Center (VSACC) & Peripheral Vascular Core Lab (PVCL) What are the VSACC and the PVCL? The Vascular Surgery Academic Coordinating Center (VSACC) is an academic research
More informationStudy Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)
Replaces previous version 203.01: 01 July 2014 Study Start-Up SS 203.01 STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature
More informationQUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES
QUALITY TIPS FOR CLINICAL SITES Athena Thomas-Visel Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES Purpose of presentation: Share best practices seen from 150+ sites visited Spark conversation
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Document Development and Change Control
General Administration GA 104.00 STANDARD OPERATING PROCEDURE FOR Document Development and Change Control Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval:
More informationHow to Prepare for Federal Inspections and What to Expect
How to Prepare for Federal Inspections and What to Expect Jennifer A. Graf Tufts Medical Center Tufts University Health Sciences Director of IRB Operations Originally presented at the February 2011 Society
More informationRESEARCH SUPPORTED BY A DEPARTMENT OF DEFENSE (DOD) COMPONENT
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program RESEARCH SUPPORTED BY A DEPARTMENT OF DEFENSE (DOD) COMPONENT 5/23/2011 The following special considerations apply to research involving
More informationLocal VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB
ADMINISTRATIVE INFORMATION Principal Investigator: Study Coordinator: Protocol Title: Current Audit Date: Research Compliance Officer (RCO) or Designated Auditor(s): Local VA VA ORD CSP Other VA ORD Sponsor
More informationNational Cancer Institute. Central Institutional Review Board. Standard Operating Procedures
National Cancer Institute Central Institutional Review Board Standard Operating Procedures CIRB Standard Operating Procedures Additional copies are available from the CIRB website (http://www.ncicirb.org)
More informationGenesis Health System. Institutional Review Board. Standard Operating Procedures
Genesis Health System Institutional Review Board Table of Contents 1. INSTITUTIONAL AUTHORITY... 6 2. PURPOSE... 6 3. THE SCOPE & AUTHORITY OF THE IRB... 7 Scope...7 Authority of the GHS-IRB...7 Authority
More informationHow Much Money Do you Ask for When Submitting Grant Budgets?
How Much Money Do you Ask for When Submitting Grant Budgets? Partner s Office for Women s Careers at MGH Kay Ryan, Director for Clinical Research Operations at MGH Loralie Brennen, Manager for Coordinator
More informationCLOSE OUT VISIT REPORT (NO CRF TO MONITOR)
Date: Page: 1 of 8 CLOSE OUT VISIT REPORT (NO CRF TO MONITOR) Protocol: PI Name: PI Address: Date of Visit: Monitor(s): Other Sponsor Personnel Present: Site Personnel Present at Visit (include names and
More informationPHS Interventional Study Operational Approval Request
PHS Interventional Study Operational Approval Request Operational approval is required for all interventional studies in which the protocol includes patient care provided in a PHS facility, to PHS patients,
More informationSpring 2018 Research Training Program Agenda SESSION 1, WEDNESDAY, MAY 2, 2018
SESSION 1, WEDNESDAY, MAY 2, 2018 7:45 am 8:15 am Sign-In - Refreshments provided, course materials distributed 8:15 am - 8:25 am Introduction Welcome and overview of the six session course. 8:25 am -
More informationJoint Commission International 6 th Edition: Hospital Standards. Governance, Leadership and Direction ( GLD )
Joint Commission International 6 th Edition: Hospital Standards Governance, Leadership and Direction ( GLD ) Governance, Leadership and Direction (GLD) Overview GLD Overview The term leaders is used to
More informationClinical Trial Readiness Checklist October 2014
The clinical trial readiness checklist is a tool which can help new and experienced researchers prepare for upcoming clinical studies. It is designed to be a quick reference to ensure that you have the
More informationTraining, Site Selection and Human Subject Protection: Factors to Consider When Developing a Monitoring Plan
Training, Site Selection and Human Subject Protection: Factors to Consider When Developing a Monitoring Plan Cynthia F. Kleppinger, M.D. Senior Medical Officer Office of Scientific Investigations Office
More informationThe SOP applies to all human subject research falling under the purview of the University of Missouri Institutional Review Board.
Institutional Review Board.... University of Missouri-Columbia.. Standard Operating Procedure Informed Consent Types and Elements Informed Consent Types and Elements Effective Date: December 12, 2005 Original
More informationKL2 Mentored Career Development Grant
KL2 Mentored Career Development Grant The OSU Center for Clinical & Translational Science (CCTS) KL2 Program supports the career development of investigators who have made a commitment to conduct either
More informationUniversity of South Carolina. Unanticipated Problems and Adverse Events Guidelines
University of South Carolina Unanticipated Problems and Adverse Events Guidelines These guidelines define the procedures of USC for addressing unanticipated problems involving risks to research participants
More informationReporting to the IRB How to Report the Essentials and Improve the Protection of Human Subjects
Webinar Series Reporting to the IRB How to Report the Essentials and Improve the Protection of Human Subjects April 10, 2013 Presented by: James MacFarlane Director of Board Operations About the Webinar
More informationStandard Operating Procedures
Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision
More informationInvestigator Training Program March 9, The Mechanics of Performing a Clinical Trial. Michelle Cavallerano, CCRP Mary Lou Watson, BA, RRT, CCRP
Investigator Training Program March 9, 2010 The Mechanics of Performing a Clinical Trial Michelle Cavallerano, CCRP Mary Lou Watson, BA, RRT, CCRP In Summary. Clinical trials are partnerships between sponsor,
More informationUniversity of Illinois at Chicago Human Subjects Protection Program Plan
Office for the Protection of Research Subjects (OPRS) Institutional Review Board FWA# 00000083 University of Illinois at Chicago Human Subjects Protection Program Plan 203 AOB (MC 672) 1737 West Polk Street
More informationLOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)
LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP) Effective Date: February 7, 2013 SOP Title: Study Monitoring Visits - Process for Access
More informationAudits/Inspections Be Prepared for Anything
Audits/Inspections Be Prepared for Anything Practices, laboratories, institutions, and clinics that participate in clinical trials are subject to audits by a number of different entities. As a primary
More informationSt. James s Hospital Research Governance and Support Framework
St. James s Hospital Research Governance and Support Framework 2017 2019 St. James s Hospital Research Governance & Support Framework 2017 2019 Table of Contents SECTION 1... 1 1.1 Introduction... 1 1.2
More informationRisk-Benefit Ratio and Determinations. Sarah Mumford, Ammon Pate, Annie Risenmay IRB Operations Managers University of Utah
Risk-Benefit Ratio and Determinations Sarah Mumford, Ammon Pate, Annie Risenmay IRB Operations Managers University of Utah Risk-Benefit Ratio and Determinations Nuances of Risk Determinations Direct Benefit
More informationInspections and Study Monitoring
Inspections and Study Monitoring IRB Education Series 2006 Presentation may only be reused or reprinted with written permission from the Tufts-New England Medical Center/Tufts University IRB office. Audits
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More informationFDA Inspection Readiness
FDA Inspection Readiness Richard Angelo, Ph.D. Director, Managing Consultant October 17, 2014 Agenda Reasons for Inspections Preparing for Inspections Inspection Day Inspection Outcomes 2013 Inspection
More informationDuke University School of Medicine Clinical Research Update July 2014
Duke University School of Medicine Clinical Research Update July 2014 What s New? Annual DOCR Satisfaction Survey Save the Date Clinical Research Appreciation Day Save the Date Clinical Science Day Process
More informationResearch Governance in a public health service. Dr Angela Watt Director Research Governance and Ethics AHRDMA Annual Scientific Meeting 16 June 2017
Research Governance in a public health service Dr Angela Watt Director Research Governance and Ethics AHRDMA Annual Scientific Meeting 16 June 2017 Research Governance Research Governance What & Why? A
More informationCenter for Clinical Research
Center for Clinical Research SPACE AND PARTICIPANT INTERACTIONS Clinical Research Units, Nursing, Nutrition, Specimen Processing, Assays RECRUITMENT SERVICES Consultation, advertising, screening FINANCIAL
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More informationSolutions for GCP Compliance Challenges. September 23, 2015 Northwestern University IRB Brown Bag Session
Solutions for GCP Compliance Challenges September 23, 2015 Northwestern University IRB Brown Bag Session PAMELA MASON, MPH Vice President, Mason Professional Services, LLC Adjunct Faculty, Northwestern
More informationCTN POLICIES AND PROCEDURES GUIDE
National Drug Abuse Treatment Clinical Trials Network CTN POLICIES AND PROCEDURES GUIDE April 1, 2016 V6.0 TABLE OF CONTENTS 1.0 INTRODUCTION... 1 1.1 The Clinical Trials Network Structure: Definitions
More informationIRBs IN THE COMMUNITY HOSPITAL SETTING
Harry Shulman, Esq. Davis Wright Tremaine LLP and Cynthia G. Kenny, C.M.S.C., CP, CIM IRB Specialists, Inc. Present IRBs IN THE COMMUNITY HOSPITAL SETTING Second Annual Medical Research Summit March 24-26,
More informationSolutions for GCP Compliance Challenges
Solutions for GCP Compliance Challenges September 23, 2015 Northwestern University IRB Brown Bag Session PAMELA MASON, MPH Vice President, Mason Professional Services, LLC Adjunct Faculty, Northwestern
More informationPLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS
PLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS In August 2010, the Food and Drug Administration s Center for Devices and Radiological Health (CDRH or the Center) released for public
More informationPOINT Trial Organization
3.0 STUDY ORGANIZATION The POINT study is a collaboration of established research networks connected through the leadership of the Principal investigators. Day to day operational oversight is provided
More informationNOVA SOUTHEASTERN UNIVERSITY
NOVA SOUTHEASTERN UNIVERSITY DIVISION OF RESPONSIBILITIES FOR RESEARCH AND SPONSORED PROGRAMS Vice President of Research & Technology Transfer: The responsibilities of the Vice President of Research &
More informationGood Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center
Good Clinical Practice Lisa de Blieck MPA CCRC Clinical Trials Coordination Center Good Clinical Practice (GCP) An international standard for the design, conduct, performance, monitoring, auditing, recording,
More informationComprehensive Protocol Feasibility Questionnaire
Protocol Title: Potential Principal Investigator: Regulatory Coordinators: Department Chair: PROJECT FEASIBILITY PI and Study Team: YOUR RESPONSES TO THIS SURVEY CONSTITUTE A BEST ESTIMATE OF RESOURCES
More informationThe Clinical Investigation Policy and Procedure Manual Document: CIPP
Clinical Research Credential Policy Children s Hospital is committed to assuring that all individuals who perform research are appropriately qualified to perform the roles assigned. It is also recognized
More informationDefinition of Patient-Oriented Research
1 Definition of Patient-Oriented Research Scope of definition Westfall, J. M. et al. JAMA 2007;297:403-406 2 Special features of the Canadian Strategy for Patient Oriented Research (SPOR) Essentially all
More informationAcademic Preparation in Clinical Research:
[DOI: 10.14524/CR-16-0020] Academic Preparation in Clinical Research: Experience from the Field PEER REVIEWED Carolynn Thomas Jones, DNP, MSPH, RN Joe Benner, MACPR, RAC, CCRP Kathryn Jelinek, MACPR, CCRP
More informationUConn Health Office of Clinical & Translational Research Standard Operating Procedures
Purpose and Applicability: To ensure that a Medicare Coverage Analysis is done by staff in OCTR for all research clinical trials that produce r routine clinical services (RC) to be billed to Medicare and
More informationDocumenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC
Documenting the Story of a Clinical Trial: Concept to CAPA Lori T. Gilmartin Gilmartin Consulting LLC The regulations represent the floor while ethical thinking is the sky. Dr. Thomas Moore Boston University
More informationFDA Medical Device Regulations vs. ISO 14155
Vol. 11, No. 9, September 2015 Happy Trials to You FDA Medical Device Regulations vs. ISO 14155 By Shawn Kennedy Medical device clinical trials must comply with 21 CFR Parts 11 (Electronic Records), 50
More informationPractice Advancement Initiative (PAI) Using the ASHP PAI Ambulatory Care Self-Assessment Survey
Practice Advancement Initiative (PAI) Using the ASHP PAI Ambulatory Care Self-Assessment Survey Jodie Elder, PharmD, BCPS September 14, 2017 Objectives List the key components of the Practice Advancement
More informationNN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION
NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION SOP: NN SS 401 Version No.: 2.0 Effective Date: 21Oct2016 SITE SELECTION AND QUALIFICATION Supercedes Document:
More informationBuilding Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies
Building Quality into Clinical Trials Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies Objectives Identify strategies for developing a Quality Management
More informationEffective Date: November 12, 2015 Policy Number: MHC_RP0306. Corporate Director, HRPP Institutional Official, HRPP
Policy Title: Education and Training In Human Subject Research Effective Date: November 12, 2015 Policy Number: Review Date: November 12, 2015 Section: Revised Date: Administrative Responsibility: Oversight
More informationEffectively Managing and Monitoring Controlled Substances in Research
Effectively Managing and Monitoring Controlled Substances in Research Emmelyn Kim, MA, MPH, CCRA, CHRC AVP, Research Compliance & Privacy Officer Ji Eun Kim, PhD, RPh Research Pharmacist The Office of
More informationTopics 5/16/2017. Effectively Managing and Monitoring Controlled Substances in Research
Effectively Managing and Monitoring Controlled Substances in Research Emmelyn Kim, MA, MPH, CCRA, CHRC AVP, Research Compliance & Privacy Officer Ji Eun Kim, PhD, RPh Research Pharmacist The Office of
More informationInvestigator s Role and Responsibilities
Chapter 13: Investigator s Role and Responsibilities Chapter Contents 13.1 Definition and Role of Principal Investigator (PI) 13.2 Investigator-Initiated Research and Sponsor-Investigators 13.3 Educational
More information